1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MROH7 CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA APP CTRPv2 pan-cancer AAC 0.14 0.0007
mRNA APOD CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA NEXN CTRPv2 pan-cancer AAC -0.13 0.0007
mRNA RTN4IP1 CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA GJB5 CTRPv2 pan-cancer AAC 0.15 0.0007
mRNA ADGRE5 CTRPv2 pan-cancer AAC 0.12 0.0007
mRNA GREM1 CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA MTMR9 CTRPv2 pan-cancer AAC -0.13 0.0007
mRNA ITGB4 CTRPv2 pan-cancer AAC 0.14 0.0007
Download CSV